A low-Km, rolipram-sensitive, cAMP-specific phosphodiesterase from human brain. Cloning and expression of cDNA, biochemical characterization of recombinant protein, and tissue distribution of mRNA.

This publication has 24 references indexed in Scilit:

• Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma?
  Biochemical Pharmacology, 1992
• Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.
  Thorax, 1991
• Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes
  Trends in Pharmacological Sciences, 1991
• Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors
  Trends in Pharmacological Sciences, 1990
• Molecular characterization of human and bovine rod photoreceptor cGMP phosphodiesterase α-subunit and chromosomal localization of the human gene
  Genomics, 1990
• How RNA polymerase II terminates transcription in higher eukaryotes
  Trends in Biochemical Sciences, 1989
• Stereospecific binding of the antidepressant rolipram to brain protein structures
  European Journal of Pharmacology, 1986
• Rolipram, a stereospecific inhibitor of calmodulin-independent phosphodiesterase, causes?-adrenoceptor subsensitivity in rat cerebral cortex
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1986
• Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors
  Neuropharmacology, 1983
• Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probes
  Cell, 1980